OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 42 filers reported holding OYSTER PT PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $5,494,000 | -25.6% | 291,936 | -16.6% | 0.18% | -40.1% |
Q3 2020 | $7,387,000 | -10.1% | 349,916 | +23.0% | 0.30% | -15.1% |
Q2 2020 | $8,216,000 | +3.5% | 284,485 | +25.4% | 0.36% | -22.0% |
Q1 2020 | $7,941,000 | -13.1% | 226,881 | -39.3% | 0.46% | +18.9% |
Q4 2019 | $9,141,000 | – | 374,004 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |